Avrion Mitchison – Biotech companies: Celltech and the Genetic Systems Corporation (69/120)

Avrion Mitchison – Biotech companies: Celltech and the Genetic Systems Corporation (69/120)

Avrion Mitchison - The Weizmann Institute (73/120)Подробнее

Avrion Mitchison - The Weizmann Institute (73/120)

Avrion Mitchison – Principles: not taking credit for contribution to papers (63/120)Подробнее

Avrion Mitchison – Principles: not taking credit for contribution to papers (63/120)

Avrion Mitchison – Competition and co-operation between labs (64/120)Подробнее

Avrion Mitchison – Competition and co-operation between labs (64/120)

Genomic Technology EvolutionПодробнее

Genomic Technology Evolution

Avrion Mitchison – Working for The World Health Organisation (66/120)Подробнее

Avrion Mitchison – Working for The World Health Organisation (66/120)

Avrion Mitchison – The relationship between universities and industry (70/120)Подробнее

Avrion Mitchison – The relationship between universities and industry (70/120)

Avrion Mitchison – Immunology meetings (65/120)Подробнее

Avrion Mitchison – Immunology meetings (65/120)

Avrion Mitchison – The move to University College London (67/120)Подробнее

Avrion Mitchison – The move to University College London (67/120)

Avrion Mitchison - Science, politics and religion (74/120)Подробнее

Avrion Mitchison - Science, politics and religion (74/120)

Corporate movie | Eurasian Biotechnology CompanyПодробнее

Corporate movie | Eurasian Biotechnology Company

Life Technologies, Genetic SystemsПодробнее

Life Technologies, Genetic Systems

Avrion Mitchison - The role of the zoo (72/120)Подробнее

Avrion Mitchison - The role of the zoo (72/120)

Avrion Mitchison - My time as President of the Zoological Society (71/120)Подробнее

Avrion Mitchison - My time as President of the Zoological Society (71/120)

Microgenomics 2021 announcementПодробнее

Microgenomics 2021 announcement

Would you go for 5 or 20 billion cells? Two options for CAR T cell manufacturingПодробнее

Would you go for 5 or 20 billion cells? Two options for CAR T cell manufacturing